Cancer and Anesthesia: Survival After Radical Surgery - a Comparison Between Propofol or Sevoflurane Anesthesia

NCT01975064 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 5774

Last updated 2022-12-14

No results posted yet for this study

Summary

The purpose of this study is to determine whether anesthesia maintained with propofol results in better one- and five-year-survival than anesthesia maintained with sevoflurane.

Conditions

  • Breast Neoplasms
  • Colonic Neoplasms
  • Rectal Neoplasms

Interventions

DRUG

Propofol

Propofol will be infused individually for a sufficient level of anesthesia during the entire surgical procedure.

DRUG

Sevoflurane

Sevoflurane will be administered by vaporizer individually for a sufficient level of anesthesia during the entire surgical procedure.

Sponsors & Collaborators

  • Region Örebro County

    collaborator OTHER
  • University Hospital, Linkoeping

    collaborator OTHER
  • Lund University Hospital

    collaborator OTHER
  • Kalmar County Hospital

    collaborator OTHER
  • Skellefteå lasarett

    collaborator UNKNOWN
  • Wroclaw Medical University

    collaborator OTHER
  • Sundsvall Hospital

    collaborator OTHER
  • Peking University First Hospital

    collaborator OTHER
  • Helsingborgs Hospital

    collaborator OTHER
  • Air Force Military Medical University, China

    collaborator OTHER
  • RenJi Hospital

    collaborator OTHER
  • Uppsala University Hospital

    collaborator OTHER
  • University Hospital Sestre Milosrdnice

    collaborator OTHER
  • Växjö Hospital

    collaborator UNKNOWN
  • Uppsala University

    lead OTHER

Principal Investigators

  • Mats Enlund, M.D., Ph.D. · Uppsala university, Center of Clinical Research, Vasteras, Sweden

  • Leif Bergkvist, M.D., Ph.D. · Uppsala university, Center of Clinical Research, Vasteras, Sweden

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2022-08-31
Completion
2022-08-31

Countries

  • China
  • Poland
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01975064 on ClinicalTrials.gov